Evidence map›Paper›PMID 38178048›Full record

ArticleBMC neurology2024

Sustained effort network for treatment of status epilepticus/European academy of neurology registry on adult refractory status epilepticus (SENSE-II/AROUSE).

Charlotte Damien, Markus Leitinger, Christoph Kellinghaus, Adam Strzelczyk, Pia De Stefano, Christoph P Beier, Raoul Sutter, Leena Kämppi, Daniel Strbian, Erik Taubøll and 6 more

Registry-linked trialOpen access · goldAbstract readMulticenter Study
In one paragraph

Article in BMC neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05839418 (Sustained Effort Network for Treatment of Status Epilepticus/European Academy of Neurology Registry on Refractory Status Epilepticus), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05839418 recruitingnot on this map

Sustained Effort Network for Treatment of Status Epilepticus/European Academy of Neurology Registry on Refractory Status Epilepticus (SENSE-II/AROUSE)

Typeobservational_patient_registrySponsorErasme University HospitalRan2023 to 2028Enrolled3,000ConditionsStatus Epilepticus
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Radiofrequency thermocoagulation for the treatment of refractory focal status epilepticus.Epileptic disorders : international epilepsy journal with videotape · 2025
    Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 11 institutions in 9 countries.

Charlotte DamienDepartment of Neurology, Hôpital Universitaire de Bruxelles, Hôpital Erasme, Brussels, Belgium.
Markus LeitingerDepartment of Neurology Neurointensive Care and Neurorehabilitation, Centre for Cognitive Neuroscience, Christian Doppler University Hospital, Paracelsus Medical University, European Reference Network EpiCARE, Salzburg, Austria.
Christoph KellinghausEpilepsy Center Münster-Osnabrück, Klinikum Osnabrück, Osnabrück, Germany.
Adam StrzelczykDepartment of Neurology and Epilepsy Center Frankfurt Rhine-Main, Goethe-University and University Hospital Frankfurt, Frankfurt am Main, Germany.
Pia De StefanoEEG & Epilepsy Unit, Department of Clinical Neurosciences, University Hospital of Geneva, Geneva, Switzerland.
Christoph P BeierDepartment of Neurology, Odense University Hospital, Odense, Denmark.
Raoul SutterDepartment of Neurology, University Hospital Basel, Basel, Switzerland.
Leena KämppiDepartment of Neurology, Epilepsia Helsinki, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Daniel StrbianDepartment of Neurology, Epilepsia Helsinki, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Erik TaubøllDepartment of Neurology, Oslo University Hospital, Oslo, Norway.
Felix RosenowDepartment of Neurology and Epilepsy Center Frankfurt Rhine-Main, Goethe-University and University Hospital Frankfurt, Frankfurt am Main, Germany.
Raimund HelbokDepartment of Neurology, Johannes Kepler University Linz, Linz, Austria.
Stephan RüeggDepartment of Neurology, Epilepsia Helsinki, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Maxwell DamianDepartment of Critical Care, Essex Cardiothoracic Centre, Basildon, UK.
Eugen TrinkaDepartment of Neurology Neurointensive Care and Neurorehabilitation, Centre for Cognitive Neuroscience, Christian Doppler University Hospital, Paracelsus Medical University, European Reference Network EpiCARE, Salzburg, Austria.
Nicolas GaspardDepartment of Neurology, Hôpital Universitaire de Bruxelles, Hôpital Erasme, Brussels, Belgium. Nicolas.Gaspard@hubruxelles.be.
University of Helsinki · FIErasmus Hospital · BEGoethe University Frankfurt · DEParacelsus Medical University · ATEssex Cardiothoracic Centre · GBJohannes Kepler University of Linz · ATKlinikum Osnabrück · DEOdense University Hospital · DKOslo University Hospital · NOUniversity Hospital of Basel · CHUniversity Hospital of Geneva · CH

Funding

Swiss National Foundation 320030_169379
6 · The paper itself

Abstract

backgroundStatus Epilepticus (SE) is a common neurological emergency associated with a high rate of functional decline and mortality. Large randomized trials have addressed the early phases of treatment for convulsive SE. However, evidence regarding third-line anesthetic treatment and the treatment of nonconvulsive status epilepticus (NCSE) is scarce. One trial addressing management of refractory SE with deep general anesthesia was terminated early due to insufficient recruitment. Multicenter prospective registries, including the Sustained Effort Network for treatment of Status Epilepticus (SENSE), have shed some light on these questions, but many answers are still lacking, such as the influence exerted by distinct EEG patterns in NCSE on the outcome. We therefore initiated a new prospective multicenter observational registry to collect clinical and EEG data that combined may further help in clinical decision-making and defining SE.

methodsSustained effort network for treatment of status epilepticus/European Academy of Neurology Registry on refractory Status Epilepticus (SENSE-II/AROUSE) is a prospective, multicenter registry for patients treated for SE. The primary objectives are to document patient and SE characteristics, treatment modalities, EEG, neuroimaging data, and outcome of consecutive adults admitted for SE treatment in each of the participating centers and to identify factors associated with outcome and refractoriness. To reach sufficient statistical power for multivariate analysis, a cohort size of 3000 patients is targeted. DISCUSSION: The data collected for the registry will provide both valuable EEG data and information about specific treatment steps in different patient groups with SE. Eventually, the data will support clinical decision-making and may further guide the planning of clinical trials. Finally, it could help to redefine NCSE and its management.

trial registrationNCT number: NCT05839418.

Indexed as

Status EpilepticusAdultAnticonvulsantsElectroencephalographyHumansMultivariate AnalysisProspective StudiesRegistriesAnticonvulsantsAnti-seizure medicationContinuous intravenous anesthetic DrugsEEGOutcomeRefractorinessStatus Epilepticus

Identifiers

PMID38178048
PMCPMC10765797
OpenAlexW4390585367

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.